SuperworthBiomarin Pharmaceutical shares outstanding BMRN
Diluted shares outstanding, averaged over each quarter, from 2009.
- Latest quarter, to Jun 30, 2026
- 194.5M
- On a year earlier
- −1.3%
- fewer shares
Biomarin Pharmaceutical had 194.5M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 1.3% fewer than a year earlier, so each share owns a little more of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 192.2M | −2% |
| FY2024 | 196.8M | +8% |
| FY2023 | 181.4M | −3% |
| FY2022 | 186M | +1% |
| FY2021 | 183.6M | +1% |
| FY2020 | 181.9M | +1% |
| FY2019 | 179.5M | +1% |
| FY2018 | 177.9M | +1% |
| FY2017 | 175.5M | +2% |
| FY2016 | 172M | +7% |
| FY2015 | 161.1M | +9% |
| FY2014 | 148.2M | +4% |
| FY2013 | 142.7M | +14% |
| FY2012 | 124.6M | +9% |
| FY2011 | 114.4M | +7% |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 194.5M | −1% | |
| Q1 FY26 | 197.7M | +1% | |
| Q4 FY25 | 192.2M | −2% | |
| Q3 FY25 | 192M | −3% | |
| Q2 FY25 | 197.1M | −2% | |
| Q1 FY25 | 196.5M | −1% | |
| Q4 FY24 | 196.8M | +8% | |
| Q3 FY24 | 197.1M | +3% | |
| Q2 FY24 | 200.5M | +3% | |
| Q1 FY24 | 199.3M | +3% | |
| Q4 FY23 | 181.4M | −3% | |
| Q3 FY23 | 191.2M | +3% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Biomarin Pharmaceutical
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.